![Gregory N. Dietsch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gregory N. Dietsch
Hoofd Techniek/Wetenschap/O&O bij VentiRx Pharmaceuticals, Inc.
Actieve functies van Gregory N. Dietsch
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VentiRx Pharmaceuticals, Inc.
![]() VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Hoofd Techniek/Wetenschap/O&O | - | - |
American Board of Toxicology | Corporate Officer/Principal | - | - |
Loopbaan van Gregory N. Dietsch
Eerdere bekende functies van Gregory N. Dietsch
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ICOS Corp.
![]() ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | - | - |
Opleiding van Gregory N. Dietsch
Washington State University | Graduate Degree |
Oregon Health & Science University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
VentiRx Pharmaceuticals, Inc.
![]() VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Health Technology |
ICOS Corp.
![]() ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
American Board of Toxicology |
- Beurs
- Insiders
- Gregory N. Dietsch
- Ervaring